Chestionar haq poliartrita, Chestionar in poliartrita reumatoida

osteochondroza unguentului coloanei cervicale

Source: Romanian Journal of Rheumatology. Patients and methods: The translation of the original version of the SHAQ has been performed by the "forwardbackward" method.

Artrita reumatoida a mainilor

Fifty-four SSc patients hospitalized in two rheumatology clinics of Bucharest were included and extensively investigated. Thirty-one of these, whose condition was considered stable, completed again the questionnaire 3 to 5 days after the first administration.

un deget mic pe articole

Scalability, reproducibility, internal consistency, construct validity and discriminative capacity of the index were assessed. Results: Forty-seven female and 7 male SSc patients answered the questionnaire. Mean age was Reproducibility was also excellent Spearman r 0.

tratamentul plasmatic al artrozei articulare

Internal consistency was demonstrated by a good Cronbach alpha coefficient 0. Construct validity was demonstrated by moderate, but significant correlations Spearman. English Copyright of Romanian Journal of Rheumatology is the property of Amaltea Medical Publishing House and its content may not be copied or emailed to multiple sites or posted to a listserv tratamentul osteoartrozei carpiene the copyright holder's express written permission.

However, users may print, download, or email articles for individual use.

mouse ul durerii articulare

This abstract may be abridged. No warranty is given about the accuracy of the copy.

osteoartrita gelurilor de unguent la genunchi

Users should refer to the original published version of the material for the chestionar haq poliartrita abstract. Important User Information: Remote access to EBSCO's databases is permitted to patrons of subscribing institutions accessing from remote locations for personal, non-commercial use.

tratamentul artritei reumatoide la degete

However, remote access to EBSCO's databases from non-subscribing institutions is not allowed if the purpose of the use is for commercial gain through cost reduction or avoidance for a non-subscribing institution.